The Food and Drug Administration (FDA) has authorized a monoclonal antibody cocktail as a measure to prevent infection in some groups of people who were exposed to the CCP virus, the pathogen that causes COVID-19.
The U.S. Food and Drug Administration (FDA) is calling on Pfizer and Moderna to recruit more children into their respective Wuhan coronavirus (Covid-19) “vaccine” trials.
Nearly 400 children between the ages of 12 and 17 were diagnosed with heart inflammation after receiving the Pfizer-BioNTech COVID-19 vaccine, according to a study published by the Centers for Disease Control and Prevention (CDC) on July 30.
Antibody testing is critical for determining COVID vaccine efficacy and necessity, but FDA continues to recommend against the testing for anyone, including people who already had COVID and those who have been vaccinated against the virus.
Pfizer hiked its projections for COVID vaccine revenues, telling investors this week it expects booster shots, a vaccine targeting the Delta variant and anticipated authorization of its vaccines for children as young as 6 months will drive revenues higher.
A Wall Street Journal op-ed claims the FDA is "attacking a safe, effective drug," Ivermectin, even though the FDA itself certified the medication in 1996.
